 LONDON and DUBLIN, April 23, 2021 GLOBE NEWSWIRE -- GW Pharmaceuticals plc Nasdaq: GWPH GW and Jazz Pharmaceuticals plc Nasdaq: JAZZ Jazz today announced that GWs shareholders voted to approve the acquisition of GW by a subsidiary of Jazz or its nominees at the GW shareholder meetings held today. The proposals required to be approved by GWs shareholders in order to complete the acquisition were each approved. In addition, the non-binding, advisory proposal to approve certain compensation arrangements for GWs named executive officers was approved. Detailed information regarding the results will be made available by GW in a filing with the U.S. Securities and Exchange Commission SEC. 